Patients with Osteoporosis on Steroid Medication Tend to Sustain Subsequent Fractures

References

1. ↵
   Deramond H, Depriester C, Galibert P, et al. Percutaneous vertebroplasty with polymethylmethacrylate. Technique, indications, and results. Radiol Clin North Am 1998;36:533–46

   CrossRefPubMedWeb of Science
2. Martin JB, Jean B, Sugiu K, et al. Vertebroplasty: clinical experience and follow-up results. Bone 1999;25(2 Suppl):11S–15S
3. Heini PF, Walchli B, Berlemann U. Percutaneous transpedicular vertebroplasty with PMMA: operative technique and early results. A prospective study for the treatment of osteoporotic compression fractures. Eur Spine J 2000;9:445–50

   CrossRefPubMedWeb of Science
4. McGraw JK, Lippert JA, Minkus KD, et al. Prospective evaluation of pain relief in 100 patients undergoing percutaneous vertebroplasty: results and follow-up. J Vasc Interv Radiol 2002;13:883–86

   PubMedWeb of Science
5. Evans AJ, Jensen ME, Kip KE, et al. Vertebral compression fractures: pain reduction and improvement in functional mobility after percutaneous polymethylmethacrylate vertebroplasty retrospective report of 245 cases. Radiology 2003;226:366–72

   PubMedWeb of Science
6. ↵
   Phillips FM. Minimally invasive treatments of osteoporotic vertebral compression fractures. Spine 2003;28(15 Suppl):S45–53
7. ↵
   Grados F, Depriester C, Cayrolle G, et al. Long-term observations of vertebral osteoporotic fractures treated by percutaneous vertebroplasty. Rheumatology (Oxford) 2000;39:1410–14

   Abstract/FREE Full Text
8. Uppin AA, Hirsch JA, Centenera LV, et al. Occurrence of new vertebral body fracture after percutaneous vertebroplasty in patients with osteoporosis. Radiology 2003;226:119–24

   PubMedWeb of Science
9. Lin EP, Ekholm S, Hiwatashi A, et al. Vertebroplasty: cement leakage into the disc increases the risk of new fracture of adjacent vertebral body. AJNR Am J Neuroradiol 2004;25:175–80

   Abstract/FREE Full Text
10. Kim SH, Kang HS, Choi JA, et al. Risk factors of new compression fractures in adjacent vertebrae after percutaneous vertebroplasty. Acta Radiol 2004;45:440–45

    CrossRefPubMed
11. Syed MI, Patel NA, Jan S, et al. New symptomatic vertebral compression fractures within a year following vertebroplasty in osteoporotic women. AJNR Am J Neuroradiol 2005;26:1601–04

    Abstract/FREE Full Text
12. Trout AT, Kallmes DF, Kaufmann TJ. New fractures after vertebroplasty: adjacent fractures occur significantly sooner. AJNR Am J Neuroradiol 2006;27:217–23

    Abstract/FREE Full Text
13. ↵
    Voormolen MH, Lohle PN, Juttmann JR, et al. The risk of new osteoporotic vertebral compression fractures in the year after percutaneous vertebroplasty. J Vasc Interv Radiol 2006;17:71–76

    CrossRefPubMedWeb of Science
14. ↵
    Harrop JS, Prpa B, Reinhardt MK, et al. Primary and secondary osteoporosis’ incidence of subsequent vertebral compression fractures after kyphoplasty. Spine 2004;29:2120–25

    CrossRefPubMedWeb of Science
15. ↵
    Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001;285:320–23

    CrossRefPubMedWeb of Science
16. ↵
    Fribourg D, Tang C, Sra P, et al. Incidence of subsequent vertebral fracture after kyphoplasty. Spine 2004;29:2270–76; discussion 2277

    CrossRefPubMedWeb of Science
17. ↵
    Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112:352–64

    CrossRefPubMedWeb of Science
18. Reid IR, Heap SW. Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med 1990;150:2545–48

    CrossRefPubMedWeb of Science
19. Manolagas SC, Weinstein RS. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999;14:1061–66

    CrossRefPubMedWeb of Science
20. Walsh LJ, Lewis SA, Wong CA, et al. The impact of oral corticosteroid use on bone mineral density and vertebral fracture. Am J Respir Crit Care Med 2002;166:691–95

    CrossRefPubMedWeb of Science
21. ↵
    Saag KG, Emkey R, Schnitzer TJ, et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 1998;339:292–99

    CrossRefPubMedWeb of Science
22. ↵
    Chavassieux PM, Arlot ME, Roux JP, et al. Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies. J Bone Miner Res 2000;15:754–62

    CrossRefPubMedWeb of Science
23. ↵
    Westesson PL, Lee RK, Ketkar MA, et al. Underdiagnosis and undertreatment of osteoporosis. Lancet 2002;360:1891

    PubMed